University of California, San Francisco
San Francisco, California, 94158, United States
NCT Number: NCT07277595
kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
San Francisco, California, 94158, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation
Participants receive kTMP active stimulation for 18 weeks
Time frame: Enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34.
The Fugl-Meyer Assessment (FMA) is a structured evaluation used to measure motor recovery after a stroke, with a total score range of 0-226. Higher scores indicate better motor function, while lower scores reflect greater impairment.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Measures timed functional tasks, strength testing, and analysis of movement quality when completing various upper extremity tasks. Uses a 6 point ordinal scale (0-5), where ) is does not attempt with the involved arm and 5 is arm does participate and movement appears normal. Maximum score of 75. Lower scores indicate lower functional levels.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Self reported questionnaire that evaluates disability and health related quality of life after stroke, consisting of 59 items, assessing strength, hand function, ADL/iADL, mobility, communication, emotion, memory and thinking, participation/role function. Each item is rated in a 5 point Likert scale, where 1 equals could not do it at all and 5 equals not difficult at all. Score ranges 0-100. Higher score indicates less disability and high quality of life after stroke.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Questionnaire consisting of 49 items in the 12 domains of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking and personality. Each item is assessed on a 5 point Guttman type scale, where 1=total help; couldn't do it at all; strongly agree and 5 =no help needed; no trouble at all; strongly disagree. Higher scores indicate better functioning.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
A health questionnaire that measures 5 dimensions including mobility, self-care, usual activities, pain/discomfort, anxiety/depression. Each item is described by 3 levels of problems, where 1=none, 2=mild to moderate, and 3=severe. This provides a simple single index value for health status, where a higher score indicates worse health state.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Self reported perception of Quality of movement are rated in 30 functional tasks, scored on a 6 point ordinal scale where 0=weaker arm not used at all for that activity and 5=ability to use the weaker arm for that activity is as good as before the stroke(normal). A higher score indicates better quality upper extremity movement.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Test of resistance to passive movement about a joint, scores range from 0 to 5 where 0=no increase in muscle tone and 5=affected part(s) rigid. Hight scores indicate greater muscle tone.
Time frame: At enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34
Measures performance of the upper extremity in grasp, grip, pinch, and gross arm movements, rated on a 4 point ordinal scale where 3=performs test normally and 0=can perform no part of test. Higher score indicates greater function of the upper extremity.
Contact information is provided by the study sponsor or research team.
University of California, San Francisco
Other
KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.
Acronym: KULMINATE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631078
Arm Weakness as a Consequence of Stroke, Brain Diseases
San Francisco, California, United States
View Trial DetailsNCT06765642
Arm Weakness as a Consequence of Stroke, Brain Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07499310
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT07226518
Brain Diseases, Cardiovascular Diseases
Kansas City, Kansas, United States
View Trial Details